Introductory Clinical Pharmacology Test Bank Overview
Study online at https://quizlet.com/_gvsebs
1. Pharmacology: The study of drugs and their action on living organisms.
2. Drug action: How the drug acts in the body; considered the most critical aspect
of pharmacology.
3. Clinical drug reference: A source for obtaining information about a drug and its
actions.
4. Clinical pharmacist: A healthcare professional who provides information about
drugs.
5. Sources for deriving medications: Plants, synthetic sources, mold, minerals,
and animals.
6. Chemical name: A name assigned to a drug during the development process
that reflects its chemical structure.
7. Official name: A name assigned to a drug that is recognized by official regulatory
bodies.
8. Pharmacologic name: A name that describes the pharmacological properties of
the drug.
9. Trade name: A brand name assigned to a drug by its manufacturer.
10. Nonproprietary name: Also known as the generic name, it is a name assigned
to a drug that is not trademarked.
11. Drug classification: The categorization of a drug based on the chemical type
of its active ingredient or its therapeutic use.
12. Active ingredient: The chemical component in a drug that is responsible for its
therapeutic effects.
13. Food and Drug Administration (FDA): The agency responsible for assigning
categories to newly approved drugs in the United States.
14. Drug name: The name by which a drug is known, which can include chemical,
official, pharmacologic, trade, and nonproprietary names.
15. Drug class: A category that groups drugs based on their similar properties or
effects.
16. Drug source: The origin of a drug, which can be natural or synthetic.
17. Synthetic sources: Drugs created in a laboratory setting.
18. Mold: A natural source from which some medications are derived.
19. Minerals: Natural substances that can be used as sources for medications.
20. Animals: Natural sources from which some medications are derived.
21. Nursing instructor: An educator who teaches nursing students about pharma-
cology and other subjects.
22. Nurse assigned to the patient: A healthcare professional responsible for the
care of a specific patient.
23. Prescribing health care provider: A medical professional who prescribes med-
ications to patients.
, Introductory Clinical Pharmacology Test Bank Overview
Study online at https://quizlet.com/_gvsebs
24. Prescription: A category assigned by the FDA to drugs that require a licensed
health care provider's signature.
25. Nonprescription: A category assigned by the FDA to drugs that can be pur-
chased without a prescription, often referred to as over-the-counter drugs.
26. Controlled substance: A category assigned by the FDA to drugs that are
regulated due to their potential for abuse.
27. Metabolite: The inactive form of the drug.
28. Noncontrolled substance: A term that is not used in the context of drug
classification.
29. Safe use of prescription drugs: Includes administering drugs, monitoring drug
effects, evaluating for toxic effects, and educating clients and caregivers about drugs.
30. Prescription documentation: Must contain the client's name, the name of the
drug, the dosage, the method and times of administration, and the signature of the
licensed health care provider.
31. Nonprescription drugs labeling requirements: Federal government has im-
posed labeling requirements for OTC drugs, which should only be taken as directed
on the label.
32. Controlled Substances Act of 1970: Regulates the manufacture, distribution,
and dispensing of drugs classified as controlled substances.
33. Manufacturing: One of the activities regulated under the Controlled Substances
Act for controlled substances.
34. Distribution: One of the activities regulated under the Controlled Substances
Act for controlled substances.
35. Dispensing: One of the activities regulated under the Controlled Substances
Act for controlled substances.
36. Monitoring clients for drug effects: An important responsibility of nurses to
ensure the safe use of prescription drugs.
37. Evaluating clients for toxic effects: An important responsibility of nurses to
ensure the safe use of prescription drugs.
38. Educating clients/caregivers about drugs: An important responsibility of
nurses to ensure the safe use of prescription drugs.
39. Dosage of the drug: A required element that must be documented in a prescrip-
tion.
40. Route of drug administration: A required element that must be documented
in a prescription.
41. Times of drug administration: A required element that must be documented
in a prescription.
42. Licensed prescriber's signature: A required element that must be document-
ed in a prescription.
, Introductory Clinical Pharmacology Test Bank Overview
Study online at https://quizlet.com/_gvsebs
43. Over-the-counter drugs: Another term for nonprescription drugs that do not
require a prescription.
44. Elimination: The excretion of drugs from the body, a pharmacokinetic activity.
45. Orphan Drug Program: A program that encourages the development and mar-
keting of products to treat rare diseases.
46. Provisional Approval: Approval granted with a written commitment from the
drug company to formally demonstrate client benefits.
47. Incentives in Orphan Drug Program: Research grants, protocol assistance,
and special tax credits provided to develop products to treat rare diseases.
48. Exclusive Marketing Rights: 7 years of exclusive marketing rights granted to
the manufacturer if the drug is approved.
49. Accelerated Approval: Approval of drugs based on preliminary evidence before
formal demonstration of client benefits.
50. Pharmacokinetic Phases: The phases of pharmacokinetics include absorp-
tion, distribution, metabolism, and excretion.
51. ADME: An acronym to remember the pharmacokinetic phases: Absorption,
Distribution, Metabolism, Excretion.
52. Absorption: The process by which drug particles in the GI tract are moved into
the body fluids.
53. Active Transport: A mechanism for absorption in the gastrointestinal tract.
54. Passive Transport: A mechanism for absorption in the gastrointestinal tract.
55. Pinocytosis: A mechanism for absorption in the gastrointestinal tract.
56. Half-life: The measure of the rate at which drugs are removed from the body.
57. Renal Disease Effect on Half-life: Half-life can be decreased in clients with
renal disease.
58. Liver Disease Effect on Half-life: Liver disease can increase half-life.
59. Dosing Frequency: Half-life can help determine dosing frequency.
60. Change in Half-life: Half-life does not change throughout a client's life.
61. Anaphylactic Shock Indicators: Signs that alert the nurse to suspect that the
client is developing anaphylactic shock.
62. Bradycardia: A condition where the heart rate is slower than normal.
63. Hypertension: A condition characterized by consistently elevated blood pres-
sure.
64. Dyspnea: A medical term for shortness of breath or difficulty breathing.
65. Urticaria: A skin reaction that causes itchy welts or hives.
66. Angioedema: A type of allergic drug reaction manifested by swelling in the
deeper layers of the skin, often affecting the eyelids, lips, and throat.
67. Factors altering drug response in children: Factors include slower gastric
emptying, greater surface area, less protein binding, and less cutaneous fat.
Study online at https://quizlet.com/_gvsebs
1. Pharmacology: The study of drugs and their action on living organisms.
2. Drug action: How the drug acts in the body; considered the most critical aspect
of pharmacology.
3. Clinical drug reference: A source for obtaining information about a drug and its
actions.
4. Clinical pharmacist: A healthcare professional who provides information about
drugs.
5. Sources for deriving medications: Plants, synthetic sources, mold, minerals,
and animals.
6. Chemical name: A name assigned to a drug during the development process
that reflects its chemical structure.
7. Official name: A name assigned to a drug that is recognized by official regulatory
bodies.
8. Pharmacologic name: A name that describes the pharmacological properties of
the drug.
9. Trade name: A brand name assigned to a drug by its manufacturer.
10. Nonproprietary name: Also known as the generic name, it is a name assigned
to a drug that is not trademarked.
11. Drug classification: The categorization of a drug based on the chemical type
of its active ingredient or its therapeutic use.
12. Active ingredient: The chemical component in a drug that is responsible for its
therapeutic effects.
13. Food and Drug Administration (FDA): The agency responsible for assigning
categories to newly approved drugs in the United States.
14. Drug name: The name by which a drug is known, which can include chemical,
official, pharmacologic, trade, and nonproprietary names.
15. Drug class: A category that groups drugs based on their similar properties or
effects.
16. Drug source: The origin of a drug, which can be natural or synthetic.
17. Synthetic sources: Drugs created in a laboratory setting.
18. Mold: A natural source from which some medications are derived.
19. Minerals: Natural substances that can be used as sources for medications.
20. Animals: Natural sources from which some medications are derived.
21. Nursing instructor: An educator who teaches nursing students about pharma-
cology and other subjects.
22. Nurse assigned to the patient: A healthcare professional responsible for the
care of a specific patient.
23. Prescribing health care provider: A medical professional who prescribes med-
ications to patients.
, Introductory Clinical Pharmacology Test Bank Overview
Study online at https://quizlet.com/_gvsebs
24. Prescription: A category assigned by the FDA to drugs that require a licensed
health care provider's signature.
25. Nonprescription: A category assigned by the FDA to drugs that can be pur-
chased without a prescription, often referred to as over-the-counter drugs.
26. Controlled substance: A category assigned by the FDA to drugs that are
regulated due to their potential for abuse.
27. Metabolite: The inactive form of the drug.
28. Noncontrolled substance: A term that is not used in the context of drug
classification.
29. Safe use of prescription drugs: Includes administering drugs, monitoring drug
effects, evaluating for toxic effects, and educating clients and caregivers about drugs.
30. Prescription documentation: Must contain the client's name, the name of the
drug, the dosage, the method and times of administration, and the signature of the
licensed health care provider.
31. Nonprescription drugs labeling requirements: Federal government has im-
posed labeling requirements for OTC drugs, which should only be taken as directed
on the label.
32. Controlled Substances Act of 1970: Regulates the manufacture, distribution,
and dispensing of drugs classified as controlled substances.
33. Manufacturing: One of the activities regulated under the Controlled Substances
Act for controlled substances.
34. Distribution: One of the activities regulated under the Controlled Substances
Act for controlled substances.
35. Dispensing: One of the activities regulated under the Controlled Substances
Act for controlled substances.
36. Monitoring clients for drug effects: An important responsibility of nurses to
ensure the safe use of prescription drugs.
37. Evaluating clients for toxic effects: An important responsibility of nurses to
ensure the safe use of prescription drugs.
38. Educating clients/caregivers about drugs: An important responsibility of
nurses to ensure the safe use of prescription drugs.
39. Dosage of the drug: A required element that must be documented in a prescrip-
tion.
40. Route of drug administration: A required element that must be documented
in a prescription.
41. Times of drug administration: A required element that must be documented
in a prescription.
42. Licensed prescriber's signature: A required element that must be document-
ed in a prescription.
, Introductory Clinical Pharmacology Test Bank Overview
Study online at https://quizlet.com/_gvsebs
43. Over-the-counter drugs: Another term for nonprescription drugs that do not
require a prescription.
44. Elimination: The excretion of drugs from the body, a pharmacokinetic activity.
45. Orphan Drug Program: A program that encourages the development and mar-
keting of products to treat rare diseases.
46. Provisional Approval: Approval granted with a written commitment from the
drug company to formally demonstrate client benefits.
47. Incentives in Orphan Drug Program: Research grants, protocol assistance,
and special tax credits provided to develop products to treat rare diseases.
48. Exclusive Marketing Rights: 7 years of exclusive marketing rights granted to
the manufacturer if the drug is approved.
49. Accelerated Approval: Approval of drugs based on preliminary evidence before
formal demonstration of client benefits.
50. Pharmacokinetic Phases: The phases of pharmacokinetics include absorp-
tion, distribution, metabolism, and excretion.
51. ADME: An acronym to remember the pharmacokinetic phases: Absorption,
Distribution, Metabolism, Excretion.
52. Absorption: The process by which drug particles in the GI tract are moved into
the body fluids.
53. Active Transport: A mechanism for absorption in the gastrointestinal tract.
54. Passive Transport: A mechanism for absorption in the gastrointestinal tract.
55. Pinocytosis: A mechanism for absorption in the gastrointestinal tract.
56. Half-life: The measure of the rate at which drugs are removed from the body.
57. Renal Disease Effect on Half-life: Half-life can be decreased in clients with
renal disease.
58. Liver Disease Effect on Half-life: Liver disease can increase half-life.
59. Dosing Frequency: Half-life can help determine dosing frequency.
60. Change in Half-life: Half-life does not change throughout a client's life.
61. Anaphylactic Shock Indicators: Signs that alert the nurse to suspect that the
client is developing anaphylactic shock.
62. Bradycardia: A condition where the heart rate is slower than normal.
63. Hypertension: A condition characterized by consistently elevated blood pres-
sure.
64. Dyspnea: A medical term for shortness of breath or difficulty breathing.
65. Urticaria: A skin reaction that causes itchy welts or hives.
66. Angioedema: A type of allergic drug reaction manifested by swelling in the
deeper layers of the skin, often affecting the eyelids, lips, and throat.
67. Factors altering drug response in children: Factors include slower gastric
emptying, greater surface area, less protein binding, and less cutaneous fat.
